drugset / Trial / NCT04314726

Verify if Amelogenins Had Some Benefits in Improving Lower 2nd Molar Periodontal Healing After 3rd Molar Extraction

NCT04314726 ↗

Phase 4 Completed 5 enrolled University of Roma La Sapienza
RandomizedParallel-groupSingle-blindTreatment

Summary

Background: Prevention of periodontal defects after the extraction of lower third molars remains a challenge. Various methods have been proposed in the literature, but there are no studies which evaluated the effectiveness of amelogenins. Methods: A single-blind split-mouth randomized controlled clinical trial (RCT) was performed on 5 patients to verify if amelogenins had some benefits in improving lower second molar periodontal healing after adjacent third molar extraction. A PPD ≥ 8 mm associated with a radiographic bone defect of at least 5 mm were the main inclusion criteria.

Timeline

Start
2016-03-24
Primary completion
2018-04-20
Completion
2018-04-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amelogenin Unknown — —